Health Condition 1: D3A8- Other benign neuroendocrine tumors
Conditions
Interventions
None listed
Sponsors
Patanjali Research Foundation Trust
Eligibility
Inclusion criteria
Inclusion criteria: The age of the subject will be 18-70 years. Subjects with a malignant tumor confirmed by histopathology or cytology. Willing to participate and give consent for the study. Capability for complete compliance and completion of follow-up.
Exclusion criteria
Exclusion criteria: Known allergy to any of the active ingredients or excipients of the study drug, or have a history of allergy to other opioids or NSAIDs and their related ingredients... The subject with a known history of gastrointestinal bleeding or perforation, a positive result of fecal occult blood test during screening period, serious cardiovascular diseases, a history of an acute ischemic or hemorrhagic stroke within 6 months prior to screening, a history of significant psychiatric disorders, such as schizophrenia and depression. History of alcohol abuse or drug abuse including opioids have significant opioid contraindications. Expected pregnancy or breastfeeding. The subject who is not willing to provide consent and comply with the protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To observe the changes in quality of life in cancer patients taking Divya Cystogrit as per the treatment protocol by an ayurvedic practitioner.Timepoint: Baseline, Day 30, Day 60 | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the Numeric Pain Rating Scale (NPRS), EORTC QOL C-30, Depression-Anxiety Stress Scale (DASS-21) and Medication Adherence Report Scale (MARS). Timepoint: Baseline, Day 30th and Day 60th | — |
Countries
India
Contacts
Public ContactNikhil Mishra
Patanjali Research Institute
Outcome results
None listed